Cellestis Overview

  • Founded
  • 2000

Founded
  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $392M

Cellestis General Information

Description

Developer of medical diagnostic technologies. The company has developed and commercialized the QuantiFERON technology, a proprietary approach for early disease detection.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Acquirer
Primary Office
  • 28358 Constellation Drive
  • Unit 698
  • Valencia, CA 91355
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cellestis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 29-Aug-2011 $392M 000.00 00000 Completed Generating Revenue
3. PIPE 12-Jun-2004 00.000 000.00 Completed Generating Revenue
2. IPO 24-Apr-2001 $4.99M $4.99M 000.00 Completed Generating Revenue
1. Early Stage VC 01-Jan-2000 Completed Generating Revenue
To view Cellestis’s complete valuation and funding history, request access »

Cellestis Patents

Cellestis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2019013254-A Cell mediated immune response assay Inactive 28-Dec-2012 00000000000
US-20150330972-A1 Cell mediated immune response assay Active 28-Dec-2012 000000000
EP-2939025-B1 A cell mediated immune response assay Active 28-Dec-2012 000000000
JP-2022066193-A Cell mediated immune response assay Active 28-Dec-2012 000000000
US-20200141927-A1 Cell mediated immune response assay Pending 28-Dec-2012 A61K39/12 0
To view Cellestis’s complete patent history, request access »

Cellestis Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
M-Group PE/Buyout Minority 000 0000 000000 0
To view Cellestis’s complete investors history, request access »